Dr. Ramesh Ganju is an Endowed Professor and Vice Chair in the Department of Pathology at the Ohio State University. He obtained his PhD in Biochemistry from the Indian Institute of Science. The major focus of his lab is to elucidate mechanisms that regulate tumor growth and metastasis and to develop immune-based therapies for solid tumors. He has identified signaling pathways that regulate tumor growth, chemo-invasion, and metastasis of tumor cells, especially in breast and lung cancer. He has also elucidated the role of pro and anti-inflammatory molecules in the tumor microenvironment. He has published around 110 manuscripts.

Kenneth B Storey is a Canadian. He completed his graduation in 1971 at the University of Calgary in Biochemistry and received a doctorate in 1974 at the University of British Columbia in Zoology. He was appointed as Associate Professor in Biochemistry and Biology at Carleton University, Ottawa. His professional honors begin in 1974 - 2019 and they include the Research Excellence Award at Carleton University in 2019, the Fry Medal for the Canadian Society of Zoologists in 2011, the Killam Senior Research Fellowship in 1993-1995, And so on till the date. He addresses nearly 65 lectures as an Honorable Plenary and Keynote speaker and his Primary journal articles include a count of 845.

Dr. Dinender Singla is a translational scientist. Our team investigates the role of stem cells and their derivative exosomes in anti-cancer drug-induced cardiac toxicities and diabetes-induced muscle myopathy and cardiomyopathy. He is continuously serving to review the grants for various NIH, AHA, ministry of Italian Health, and Hong Kong study sections. He is an Academic Editor for PLoS One and associate Editor for the Canadian Journal of Physiology and Pharmacology as well and he is serving as an Editorial board member for different journals such as the American Journal of Physiology: Heart and Circulatory. He served as a chair, of the TPIG committee, the American Physiology Society, and a general secretary for the North American section of the International Academy of Cardiovascular Sciences. He is the President of the international society for adaptive Medicine. He is a fellow International Academy of Cardiovascular Sciences, the American Physiological Society, and the American Heart Association. He is a reviewer for different journals. He served as a chair for various scientific sessions throughout the world. He has also organized a scientific conference. He has published a book on stem cells and is an author/ coauthor for more than 100 peer-reviewed papers.

Dr. Helena Moreira is an Assistant Professor at the Department of Basic Medical Science of the Faculty of Pharmacy at the Wroclaw Medical University (Poland). She completed her doctoral studies at the Institute Gilbert-Laustriat (at Departement Physicochimie des Interactions Cellulaires et Moleculaires) in Strasbourg in France where she was working on the molecular mechanisms of TNF-A secretion, a key cytokine in chronic inflammation, and Dr. Moreira is deeply interested in research on cancer treatment, especially in studying the anti-cancer mechanisms of various natural plant extracts and polyphenols. She has an extensive experience in cancer research, cell cultures, and flow cytometry. Currently, her interests focus on cancer stem cells, especially in colorectal cancer. She is the organizer of many trainings and conferences and participates in many research projects.

Prof. Rony Seger became a group leader at the Weizmann Institute of Science in 1994 promoted to full professor in 2007 and was the head of the Department of Biological Regulation (2011-2017). His research group is interested in MAPK and AKT signaling and in particular in the subcellular localization of their components. Recently, the group elucidated the distinct mechanisms of nuclear translocation of ERK and p38/JNK, which are used as anti-cancer and inflammation targets. Dr. Seger published more than 230 papers, supervised more than 80 research students and post-docs, and received many prizes and awards.

PROF. HANNA ENGELBERG-KULKA was born in Vienna, Austria. She completed her MSc degree and Degree-Ph.D on the subject (Studies on streptomycin-dependent bacteria) at Hebrew University, Jerusalem, Israel and She is a Member, of the Executive Committee of the Board of Governors, Hebrew University, from 1994-2000 Chairperson, Dept of Molecular Biology, Institute of Microbiology, she was honored with the EMET prize on Genetics and The Ilanit-Kazir Prize awarded once in 3 years by the Israel Society of Experimental Biology (FISEB). This award is given to Hanna Engleberg Kulka for her pioneering research that led to the discovery of bacterial PCD and its mode of signaling, the identification of a communication factor, and The Ulizky Prize of the Israel Society of Microbiology for Excellency in microbiological research. She published 115 publications in first-class journals. Also, she is an Invited speaker for International Scientific Meetings; for the last 28 years, Her research areas are Molecular biology, Microbial genetics, biochemistry, and physiology Since 1996

Dr. Hossein Hosseinkhani, Biomedical Engineer, has 30 years of experience in biomedical engineering in both academia and industry in biomedical engineering research and development, which includes several years of basic science research experience in a number of premier institutions related to the structure and function of biomaterials, and in polymer-based medical implants development in the medical device industry. He is the inventor of 22 International patents, several of which are licensed to companies acting in the biomedical fields and translated into 7 commercial products. He authored more than 100 scientific papers published in peer-reviewed Journals, and 5 books (H-index: 48 Google Scholar). He is the founder of Matrix HT, Inc. a world-leading biotech company dedicated to healthcare technology to improve patient's quality of life.

Will Update Soon

Maria Principia Scavo: Clinical Pathologist. Dr. Maria Principia studied Biology Science at the University of Rome "La Sapienza", Italy, and graduated with an MS in 2001. She then joined the research group of Prof. Papa at the Institute of Biochemistry and Medical Biology at the University of Bari for her PhD and received her PhD degree in 2004. After 6years of postdoctoral fellowship supervised by Dr. Barone at the Gastroenterology Laboratory, University of Bari, and 3 years at the Laboratory of Nanomedicine, Methodist Research Institute of Houston, she obtained the position of a Senior Biologist at the National Institute of Gastroenterology IRCCS deBellis, Castellana Grotte BARI, ITALY. She has published more than 40 research articles in SCI(E) journals.

Hai Rao, Professor and Chair of Biochemistry, School of Medicine, Southern University of Science and Technology. Dr. Hai Rao is currently a Professor and Chair of Biochemistry at the Southern University of Science and Technology, Shenzhen, China. Prior to this position, he was a tenured professor at the University of Texas Health. His laboratory's long-term goal is to understand the mechanism and function of ubiquitin-mediated proteolysis in health and diseases (e.g., cancers and neurodegenerative disorders). His laboratory has dissected how key cellular regulators are selected for degradation by the proteasome via an integrated approach (biochemistry, biophysics, genetics, genomics, and proteomics). He has published high-impact papers in Nature, PNAS, JCB, JBC, et al. and obtained several patents for target protein degradation.

Roberto Negro obtained his Ph.D. in 2009 after a joint program between the Department of Medical Biochemistry and Medical Biology of the University of Bari Italy and the Department of Biochemistry of the Michigan State University (East Lansing, MI, USA) where his research activity was focused on the molecular analysis structural characterization of mitochondria DNA helicase Twinklein patients with altered mitochondria DNA. He then started the first postdoctoral study at the International Centre of Genetic Engineering and Biotechnology (ICGEB, located in Rome) focusing on the role of the protein tyrosine phosphatases, in particular, PTPN22, in the development of chronic lymphocytic leukemia (CLL). In 2013 he was accepted as a postdoc at the Harvard Medical School, in Boston, and started a research field on the novel intracellular mechanism of pathogens recognition named 'inflammasome'. Here he dissected the molecular and cellular mechanism of activation of two classes of inflammasomes, NLRP3 and NLRP6. In 2020 he started a position as a researcher in Italy, at the National Institute of Gastroenterology (IRCCS Saverio de Bellis, Castellana Grotte, Bari, Italy) where he is actually taking advantage of certain inflammasome aspects to suppress gastrointestinal tumor growth.

Alexei V. Finkelstein was born on 06/16/1947. Graduated from the Moscow Phys.-Tech. (1970). Ph.D. (1976, Moscow Phys.-Tech.) and D.Sc. (1991, Moscow Lomonosov Univ.) in Biophysics. Full Professor (since 1997). Since 1970, member of the Laboratory of Protein Physics (then headed by Prof. O.B. Ptitsyn) at the Institute of Protein Research, Russian Academy of Sciences. Graduate student (1971-74), junior (1974), senior (1980), leading 1996), chief (1999-) researcher at the same Laboratory. Heads this Laboratory since 1999. Head of the Department since 2017. Professor of the Moscow Lomonosov University since 1998. Professor of the Pushchino University (1993-98). Associate Professor of the Moscow Phys.-Tech. (1991-95). Soros Professor (2001). Author of 300 papers, of the book "Protein Physics", published in Russian (5 editions), English (2 editions), Chinese (2 editions), and "Physics of Protein Molecules" (in Russian). Citation index by Google Scholar: ~11000, Hirsch index: 48. Area of expertise: protein physics; protein structures, folding, and design; thermodynamics and kinetics of structural transitions in proteins and amyloids; molecular physics; phase transitions; molecular force fields; molecular biology; bioinformatics.

Will Update Soon...

Will Update Soon

Dr. Peifeng Li obtained his doctoral degree at the Chinese Academy of Medical Science. He worked as a medical researcher at the Max-Delbruck Center for Molecular Medicine, in Germany. He is currently a professor at Qingdao University, China. He has published more than 200 papers in reputed journals. He has also presented his work at many national and international professional meetings. He is one of the pioneer researchers in deciphering the molecular regulatory mechanism of microRNAs in heart disease including cardiac hypertrophy, myocardial infarction, and heart failure.

Will Update Soon...

Will Update soon

Dr. Valentina Arre graduated in 2020 in Biohealth Sciences from the University of Bari, Italy. She is currently a researcher in Italy, at the National Institute of Gastroenterology (IRCCS). Saverio de Bellis, Castellana Grotte, Bari, Italy). Her experimental research falls in the immuno-oncology field, in particular, she studies the tumor immune microenvironment in order to find novel therapeutical approaches against gastrointestinal cancer onset and development.

Will Update soon

Dr. Kazek graduated from the Faculty of Biology at the University of Warsaw with a master's degree in biology - cell and organism biology. She holds a doctoral degree in the field of biological sciences awarded by the Witold Stefanski Institute of Parasitology Polish Academy of Science. Participant in long-term internships at the Laboratory of Analytical Biochemistry and Metabolomics of the Biological Center of the Czech Academy of Sciences and the Department of Molecular Biology and Genetics at the University of South Bohemia.Laureate of the prestigious Horizon Europe grant: Marie Sklodowska-Curie Action - MSCA Postdoctoral Fellowships. Currently works as a research assistant in the Department of Microbiology, Molecular Genetics and Genomics of the Center for Advanced Materials and Technologies CEZAMAT of the Warsaw University of Technology.

Will Update Soon

Will Update Soon

Dr. Gulay Sezer is an Associate Professor at the Department of Pharmacology of the Faculty of Medicine at the Erciyes University (Turkiye). After studying Pharmacy in Ankara Hacettepe University graduated from Erciyes University in 2002 with an MS degree. She received her doctorate degree from the same institution, the Faculty of Medicine, Department of Pharmacology in 2007. During her doctorate, she had the opportunity to work in the Department of Pharmacology of the Polish Academy of Sciences in Krakow, Poland. She also teaches at the Genkok Genome and Stem Cell Center, Department of Molecular Biology and Genetics, Erciyes University. Currently, her interests focus on stem cells, cancer treatment, and prevention of chemotherapy-related side effects.